All Latest News
-
From Risk To Resolution: A Breakthrough in Nitrosamine Analysis & Mitigation
Since the release of the FDA’s guidance on Nitrosamine Drug Substance-Related Impurities (NDSRIs), the pharmaceutical industry has been diligently attempting to identify at-risk APIs, update risk assessments, and devise control... Learn More
-
Adare Expands Global High Potency Handling & Packaging Capabilities
LAWRENCEVILLE, N.J., May 1, 2024 -- Adare Pharma Solutions, a global technology-driven CDMO specializing in oral dosage forms, today announced expansions of its high potency handling capabilities in the United States and Europe. In the... Learn More
-
Adare Pharma Solutions Expanding Oral Dose Capabilities In Europe
LAWRENCEVILLE, NJ, March 12, 2024 -- Adare Pharma Solutions, a global technology-driven CDMO focused on oral dosage forms, today announced it is further investing in its Pessano facility in Milan, Italy, with the addition of a high-shear... Learn More
-
Adare Pharma Solutions To Expand Packaging & Warehousing Capabilities In Europe
LAWRENCEVILLE, NJ, March 5, 2024 -- Adare Pharma Solutions, a global technology-driven CDMO focused on oral dosage forms, today announced that work has begun to add packaging capabilities and further warehousing capacity at its Pessano... Learn More
-
Adare Pharma Solutions announces divestiture of postbiotics pioneer Adare Biome to dsm-firmenich
PHILADELPHIA, Pennsylvania, July 3, 2023 — Adare Pharma Solutions, a global technology-driven CDMO focused on oral dosage forms, today announced the completion of its divestiture of its Adare Biome business unit, a pioneer in the... Learn More
-
Meet The Experts Networking Tour 2023
Our Meet The Experts networking tour has stops across the country this summer. Come join us for happy hour and learn more about Adare straight from the experts! Let's get together and talk about how we can put our unparalleled... Learn More
-
DSM agrees to terms to acquire postbiotics pioneer Adare Biome
HEERLEN, Netherlands — April 19, 2023 Royal DSM, a global science-based leader in health, nutrition and bioscience, announces that it has entered into exclusive negotiations with Adare Pharma Solutions in order to acquire Adare Biome,... Learn More
-
Adare Pharma Solutions Selects Vantage to Lead Major Packaging Facility Upgrade
HILLSBOROUGH, NJ — March 21, 2023 Adare Pharma Solutions, a leading contract development and manufacturing organization, today announced it has selected Vantage Solutions to lead a major upgrade of their pharmaceutical packaging... Learn More
-
Global CDMO Adare Pharma Solutions Harmonizing Quality with Veeva Vault Quality Suite
Vault Quality Suite to connect quality processes, documents, and training on a single platform for improved efficiency and collaboration PLEASANTON, CA — Jan. 11, 2023Veeva Systems (NYSE: VEEV) today announced that Adare Pharma... Learn More
-
Expanded R&D Capabilities In Europe
Adare Pharma Solutions has a global network of manufacturing and development sites, with locations in the US and Europe that serve customers all over the world. We're always working to expand the capabilities of our network and its... Learn More
